Ascentage Pharma Group International (36X.F) Q1 2026 Earnings

Mar 24Confirmed
Q3 2024
Q1 2025
Q3 2025
Q1 2026
-0.21
-0.12
-0.02
0.07

Details

Expected EPS
-0.180159300912128
Actual EPS
-0.13802738272793602
Surprise EPS
0.04
Surprise Percent
+23.39%

Description

⁨Ascentage Pharma Group International⁩ (⁦36X.F⁩) has reported earnings of ⁦-0.13802738272793602⁩ per share for ⁦Q1 2026⁩.

0 Comments

Share your thoughts